Ibuprofen Protects from Cypermethrin-Induced Changes in the Striatal Dendritic Length and Spine Density

Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson’s disease

(2016) Mal-Soon Shin et al.   NEUROSCIENCE LETTERS

Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration

(2015) Ashish Singh et al.   MOLECULAR NEUROBIOLOGY

Cypermethrin alters the status of oxidative stress in the peripheral blood: relevance to Parkinsonism

(2014) Pratibha Tripathi et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism

(2014) Sonal Agrawal et al.   MOLECULAR NEUROBIOLOGY

Cypermethrin-Induced Nigrostriatal Dopaminergic Neurodegeneration Alters the Mitochondrial Function:A Proteomics Study

(2014) Sonal Agrawal et al.   MOLECULAR NEUROBIOLOGY

Aberrant Autophagy and Parkinsonism: Does Correction Rescue from Disease Progression?

(2014) Abhishek Kumar Mishra et al.   MOLECULAR NEUROBIOLOGY

Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice

(2014) Soledad Galli et al.   Nature Communications

Dual Contradictory Effect of H-89 on Neuronal Retraction, Death and Inflammation in Differentiated PC12 Cells Subjected to Oxidative Stress

(2013) Shabnam Zeighamy Alamdary et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism

(2013) Amit Naskar et al.   JOURNAL OF PINEAL RESEARCH

Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

(2013) William A. Toy et al.   NEUROBIOLOGY OF DISEASE

Differential striatal spine pathology in Parkinson’s disease and cocaine addiction: A key role of dopamine?

(2013) R.M. Villalba et al.   NEUROSCIENCE

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration

(2012) Anand Kumar Singh et al.   Current Neuropharmacology

Dendritic structural plasticity

(2011) Gaia Tavosanis   Developmental Neurobiology

MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress

(2011) Ya-Ching Hsieh et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Nigrostriatal Proteomics of Cypermethrin-Induced Dopaminergic Neurodegeneration: Microglial Activation-Dependent and -Independent Regulations

(2011) Anand Kumar Singh et al.   TOXICOLOGICAL SCIENCES

Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration

(2010) Anna Bartels et al.   Current Neuropharmacology

Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats

(2010) Katherine E. Soderstrom et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood

(2010) Anand Kumar Singh et al.   NEUROBIOLOGY OF AGING

Synaptic adhesion molecules and PSD-95

(2007) Kihoon Han et al.   PROGRESS IN NEUROBIOLOGY